1. Home
  2. CAC vs ARTL Comparison

CAC vs ARTL Comparison

Compare CAC & ARTL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Camden National Corporation

CAC

Camden National Corporation

HOLD

Current Price

$49.98

Market Cap

801.9M

Sector

Finance

ML Signal

HOLD

Logo Artelo Biosciences Inc.

ARTL

Artelo Biosciences Inc.

HOLD

Current Price

$1.27

Market Cap

3.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CAC
ARTL
Founded
1875
2011
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
801.9M
3.5M
IPO Year
1997
N/A

Fundamental Metrics

Financial Performance
Metric
CAC
ARTL
Price
$49.98
$1.27
Analyst Decision
Buy
Buy
Analyst Count
2
3
Target Price
$45.50
$30.00
AVG Volume (30 Days)
105.0K
35.2K
Earning Date
01-27-2026
03-02-2026
Dividend Yield
3.40%
N/A
EPS Growth
6.08
N/A
EPS
3.84
N/A
Revenue
$233,489,000.00
N/A
Revenue This Year
$19.32
N/A
Revenue Next Year
$5.90
N/A
P/E Ratio
$12.88
N/A
Revenue Growth
31.62
N/A
52 Week Low
$34.53
$1.15
52 Week High
$51.57
$28.60

Technical Indicators

Market Signals
Indicator
CAC
ARTL
Relative Strength Index (RSI) 60.23 30.68
Support Level $48.74 $1.35
Resistance Level $50.60 $1.52
Average True Range (ATR) 1.45 0.14
MACD -0.02 -0.04
Stochastic Oscillator 66.04 4.29

Price Performance

Historical Comparison
CAC
ARTL

About CAC Camden National Corporation

Camden National Corporation is a banking solutions provider in the United States. Its core business is providing commercial banking products to individuals and corporates. Its consumer and commercial banking services entail services such as loans and deposits, savings and online banking, treasury management solutions and non-profit products to consumer, institutional, municipal, non-profit and commercial customers. The company also offers investment management and fiduciary services.

About ARTL Artelo Biosciences Inc.

Artelo Biosciences Inc is a United States-based development-stage biopharmaceutical company. It is engaged in the development of therapeutics that target lipid signaling pathways, including the endocannabinoid system, a family of receptors & neurotransmitters that form a biochemical communication network in the body. It is focused on discovering, licensing, developing, & commercializing treatments that control endocannabinoid systems. The company pursues technologies & programs that offer proprietary approaches to cannabinoid-based therapies, & those derived from the cannabis plant & synthetic cannabinoids, as well as new chemical entities & compounds. The firm's flagship program is designed to be a patent-protected cannabinoid drug combination treatment for a rare & orphan disease.

Share on Social Networks: